Asbestos fibers can remain in the lungs for decades — in many cases, for the rest of a person’s life. Their needle-like structure allows them to penetrate deep into lung tissue where they resist the body’s natural clearing mechanisms. Once embedded, these mineral fibers cannot be broken down by the immune system, becoming permanent residents that continuously irritate surrounding tissues and can trigger serious diseases like mesothelioma, asbestosis, and lung cancer decades after the initial exposure.
At The Williams Law Firm, P.C., Attorney Joseph P. Williams has represented mesothelioma patients for more than 30 years and has seen firsthand how exposures from the 1960s and 1970s are producing diagnoses today. If you or a family member has been diagnosed with an asbestos-related disease, contact our firm for a free consultation.
Before fibers reach the lungs, they first become airborne when asbestos-containing materials are disturbed. Understanding how long they remain in the air matters because it affects how much a person inhales during and after a disturbance event.
The EPA reports that asbestos fibers can remain suspended in air for 4 to 80 hours after being released from a height of approximately 9 feet. That wide range reflects the variation in fiber size, room ventilation, and air movement. Smaller, lighter fibers remain airborne longest — sometimes for several days — while heavier fiber bundles settle faster. According to research cited by mesothelioma experts, disturbed asbestos can stay airborne for 48 to 72 hours under typical indoor conditions before settling into dust on floors and surfaces.
This is why a single disturbance event can create ongoing exposure risk: fibers that settle into carpet, upholstery, or HVAC ductwork can be re-disturbed and re-inhaled repeatedly over days or weeks. Once airborne, they are invisible and odorless — there is no sensory warning that you are breathing them in.
Understanding the unique properties of asbestos explains why these fibers can remain in the lungs permanently while other inhaled particles are cleared more easily.
Asbestos fibers possess several characteristics that enable them to evade the lungs’ natural defense mechanisms. Their microscopic size allows them to bypass the filtering systems in the nose and upper airways, traveling deep into the smallest air sacs of the lungs. Once there, their long, thin shape makes them extremely difficult for macrophages — the immune system’s cleanup cells — to engulf and remove. A macrophage that successfully surrounds a fiber can neither digest it nor expel it, and dies in the attempt, triggering further inflammation.
Unlike organic materials, asbestos is composed of durable silicate minerals that resist chemical breakdown. The body has no enzyme systems capable of dissolving or degrading these mineral fibers. This chemical stability means that once asbestos reaches the deep lung, physical removal is the only potential clearance mechanism — and the majority of fibers become too deeply embedded for this to occur.
The two major categories of asbestos behave differently once inhaled. Amphibole asbestos — including crocidolite (blue asbestos), amosite (brown asbestos), and others — has straight, rigid, needle-like fibers that penetrate tissues more effectively and are highly biopersistent, meaning they resist biological degradation almost indefinitely. Research published in NCBI NBK304374 confirms that amphibole fibers have dramatically longer retention times than serpentine fibers and are more strongly associated with mesothelioma.
Serpentine asbestos (chrysotile, or white asbestos) has curly fibers that may be partially cleared more readily — but this difference has minimal practical significance for disease prevention. Chrysotile fibers can still persist in lung tissue for decades, and even partial clearance leaves behind enough fibers to trigger ongoing inflammation and cellular damage. Any asbestos fiber type inhaled in meaningful quantities should be considered a long-term health risk.
While asbestos predominantly affects the lungs and their lining, fibers can migrate to other areas of the body through the lymphatic system, by penetrating through the lung lining into the pleural space, and via the bloodstream to distant organs. This migration explains why asbestos causes cancers and inflammation beyond the respiratory system — including peritoneal mesothelioma affecting the abdominal lining, pericardial mesothelioma affecting the heart lining, and cancers of the ovaries and larynx.
While asbestos fibers can remain indefinitely, several factors influence how many fibers stay and for how long.
Longer and thinner fibers penetrate more deeply and are more difficult for the body to remove. Fibers longer than 5 micrometers and thinner than 3 micrometers are considered the most biologically hazardous because they reach the deepest lung tissue and are least accessible to immune clearance. Shorter fibers may be partially cleared but still contribute to cumulative fiber burden over repeated or sustained exposure.
The rate at which some fibers might be cleared varies among individuals based on pre-existing lung health and respiratory conditions, smoking history (which damages the mucociliary escalator — the lung’s primary fiber-clearing mechanism), genetic factors affecting immune response, age at exposure (younger lungs may handle initial clearance differently), and overall cumulative exposure dose. These individual variations help explain why some people develop asbestos-related diseases after exposures that others with similar histories appear to tolerate — though no exposure should be considered safe.
The permanent presence of asbestos fibers in lung tissue creates ongoing biological damage through two primary mechanisms: chronic mechanical irritation and sustained inflammatory response.
The persistent nature of asbestos fibers directly causes the long latency periods associated with asbestos-related diseases. Pleural plaques — thickening of the lung lining — may develop within 10 to 20 years of exposure and are often the first detectable sign that asbestos has been inhaled. Asbestosis, the progressive scarring of lung tissue, typically manifests 15 to 30 years after exposure. Asbestos-related lung cancer usually appears 20 to 30 years post-exposure. Mesothelioma generally emerges 30 to 50 years after initial exposure, with cases documented up to 60 years after first contact.
This extended timeline means that the risk of developing an asbestos-related disease does not diminish once exposure has stopped. A worker who last handled asbestos in 1975 and has never had symptoms remains at elevated risk for mesothelioma today.
Throughout their residence in the lungs, asbestos fibers trigger a continuous inflammatory response. Immune cells repeatedly attempt to engulf the fibers, releasing inflammatory chemicals and reactive oxygen species in the process. This chronic inflammation damages surrounding tissues and contributes to scarring and the cellular mutations that may eventually lead to cancer. The fibers also physically penetrate cell membranes and interact with DNA, producing chromosomal damage that can initiate malignant transformation.
Because asbestos fibers remain in lung tissue permanently, exposure that occurred decades ago still warrants active medical monitoring today. The American Lung Association recommends that anyone with a known asbestos exposure history inform their physician and discuss baseline imaging. A chest X-ray or low-dose CT scan can detect early pleural plaques, scarring, or suspicious nodules that might indicate the earliest stages of mesothelioma, when treatment options are most effective.
There is currently no medical procedure that can remove asbestos fibers from the lungs once they are embedded. Research into therapeutic approaches remains ongoing, but as of today, management of asbestos-related disease focuses on monitoring, symptom treatment, and where malignancy develops, aggressive oncology care at a specialized center.
Because asbestos-related diseases take 20 to 50 years to develop, many workers diagnosed today were exposed during the 1960s, 1970s, and 1980s — long before they understood the risk. If you have been diagnosed with mesothelioma, asbestosis, or asbestos-related lung cancer, the permanence of asbestos in the lungs is part of why your legal claim remains valid regardless of how long ago the exposure occurred.
In New York, the statute of limitations for mesothelioma personal injury claims is three years from the date of diagnosis. In New Jersey, it is two years. Contact a New York asbestos attorney at The Williams Law Firm, P.C. to discuss your legal options. We handle all cases on a contingency fee basis — you pay nothing unless we win.
The lungs have a natural clearance system — the mucociliary escalator — that can remove some inhaled particles. Shorter asbestos fibers may be partially cleared through this mechanism and through macrophage activity. However, longer fibers, particularly amphibole types like crocidolite and amosite, are highly biopersistent and remain in lung tissue essentially permanently. The body cannot dissolve or chemically break down asbestos, and there is no current medical treatment capable of removing embedded fibers. Even fibers that are partially cleared leave behind enough burden to cause ongoing inflammation and disease risk.
The EPA reports that asbestos fibers can remain suspended in air for 4 to 80 hours after being disturbed from a height of approximately 9 feet. Under typical indoor conditions, disturbed asbestos is generally estimated to remain airborne for 48 to 72 hours before settling. Fibers that settle into carpet, dust, or HVAC ductwork can be re-disturbed and re-inhaled repeatedly over days or weeks following the initial disturbance. This is why a single renovation event involving asbestos-containing materials can create sustained exposure risk even after work has stopped.
Asbestos-related diseases have long latency periods. Pleural plaques may become detectable within 10 to 20 years. Asbestosis typically develops 15 to 30 years after significant exposure. Asbestos-related lung cancer usually appears 20 to 30 years post-exposure. Mesothelioma generally emerges 30 to 50 years after initial exposure, with some cases documented up to 60 years after first contact. This long latency means that workers exposed in the 1960s and 1970s are still being diagnosed with mesothelioma today, and the risk does not diminish once exposure has ended.
Currently, there is no medical procedure capable of removing asbestos fibers from the lungs once they are embedded. Research into therapeutic approaches continues, but as of 2026, management of asbestos exposure focuses on monitoring through periodic chest imaging and lung function testing, treating symptoms as they develop, and pursuing aggressive oncology care if malignancy is detected. Early detection through regular screening for individuals with known exposure history remains the most effective strategy for improving outcomes.
Yes, significantly. Smoking damages the mucociliary escalator — the lung’s primary fiber-clearing mechanism — which impairs the body’s limited ability to remove inhaled asbestos. The combination of smoking and asbestos exposure also has a synergistic effect on lung cancer risk, meaning the combined risk is far greater than the sum of each factor alone. Workers with both asbestos exposure and smoking history have dramatically elevated lung cancer risk compared to those with either factor independently. Quitting smoking after asbestos exposure reduces lung cancer risk, though it does not eliminate the underlying mesothelioma risk.
As the founding partner of Williams Law Firm, Joseph P. Williams has dedicated over 30 years to representing mesothelioma victims and their families. His firm has recovered hundreds of millions of dollars for those affected by asbestos exposure, offering personalized, aggressive legal advocacy. Based in New York, Williams Law Firm provides free consultations and handles cases nationwide.
